» Articles » PMID: 36009030

In Vitro Modeling of the Blood-Brain Barrier for the Study of Physiological Conditions and Alzheimer's Disease

Overview
Journal Biomolecules
Publisher MDPI
Date 2022 Aug 26
PMID 36009030
Authors
Affiliations
Soon will be listed here.
Abstract

The blood-brain barrier (BBB) is an essential structure for the maintenance of brain homeostasis. Alterations to the BBB are linked with a myriad of pathological conditions and play a significant role in the onset and evolution of neurodegenerative diseases, including Alzheimer's disease. Thus, a deeper understanding of the BBB's structure and function is mandatory for a better knowledge of neurodegenerative disorders and the development of effective therapies. Because studying the BBB in vivo imposes overwhelming difficulties, the in vitro approach remains the main possible way of research. With many in vitro BBB models having been developed over the last years, the main aim of this review is to systematically present the most relevant designs used in neurological research. In the first part of the article, the physiological and structural-functional parameters of the human BBB are detailed. Subsequently, available BBB models are presented in a comparative approach, highlighting their advantages and limitations. Finally, the new perspectives related to the study of Alzheimer's disease with the help of novel devices that mimic the in vivo human BBB milieu gives the paper significant originality.

Citing Articles

Advances in modeling permeability and selectivity of the blood-brain barrier using microfluidics.

Sun J, Song S Microfluid Nanofluidics. 2025; 28(7.

PMID: 39781566 PMC: 11709447. DOI: 10.1007/s10404-024-02741-z.


Multidisciplinary approaches in electronic nicotine delivery systems pulmonary toxicology: emergence of living and non-living bioinspired engineered systems.

Benam K Commun Eng. 2024; 3(1):123.

PMID: 39227652 PMC: 11372223. DOI: 10.1038/s44172-024-00276-3.


Unraveling neurovascular mysteries: the role of endothelial glycocalyx dysfunction in Alzheimer's disease pathogenesis.

OHare N, Millican K, Ebong E Front Physiol. 2024; 15:1394725.

PMID: 39027900 PMC: 11254711. DOI: 10.3389/fphys.2024.1394725.


Microphysiological Blood-Brain Barrier Systems for Disease Modeling and Drug Development.

Mulay A, Hwang J, Kim D Adv Healthc Mater. 2024; 13(21):e2303180.

PMID: 38430211 PMC: 11338747. DOI: 10.1002/adhm.202303180.


Mechanistic Intimate Insights into the Role of Hydrogen Sulfide in Alzheimer's Disease: A Recent Systematic Review.

Munteanu C, Iordan D, Hoteteu M, Popescu C, Postoiu R, Onu I Int J Mol Sci. 2023; 24(20).

PMID: 37895161 PMC: 10607039. DOI: 10.3390/ijms242015481.


References
1.
Song K, Harvey B, Borden M . State-of-the-art of microbubble-assisted blood-brain barrier disruption. Theranostics. 2018; 8(16):4393-4408. PMC: 6134932. DOI: 10.7150/thno.26869. View

2.
Neuhaus W, Gaiser F, Mahringer A, Franz J, Riethmuller C, Forster C . The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier. Front Cell Neurosci. 2014; 8:352. PMC: 4211409. DOI: 10.3389/fncel.2014.00352. View

3.
Thomsen L, Burkhart A, Moos T . A Triple Culture Model of the Blood-Brain Barrier Using Porcine Brain Endothelial cells, Astrocytes and Pericytes. PLoS One. 2015; 10(8):e0134765. PMC: 4524625. DOI: 10.1371/journal.pone.0134765. View

4.
Gifre-Renom L, Daems M, Luttun A, Jones E . Organ-Specific Endothelial Cell Differentiation and Impact of Microenvironmental Cues on Endothelial Heterogeneity. Int J Mol Sci. 2022; 23(3). PMC: 8836165. DOI: 10.3390/ijms23031477. View

5.
Bellenguez C, Kucukali F, Jansen I, Kleineidam L, Moreno-Grau S, Amin N . New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet. 2022; 54(4):412-436. PMC: 9005347. DOI: 10.1038/s41588-022-01024-z. View